US 6632945
Inhibitors of P38
expired A61PA61P1/00A61P1/02
Quick answer
US patent 6632945 (Inhibitors of P38) held by Vertex Pharmaceuticals Incorporated expires Mon Oct 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Oct 14 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61P, A61P1/00, A61P1/02, A61P1/04, A61P1/16